Phase I Trial Commences Treating Patients With Pancreatic And Colorectal Cancer Using Novel Monoclonal Antibody

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

Neogenix Oncology, Inc. (Neogenix) announced that the Johns Hopkins Hospital has initiated a Phase I trial with the company's first therapeutic antibody, NPC-1C, in patients with late stage pancreatic or colorectal cancer.



Fri Jun 04, 2010 02:18 AM

Would this work on late stage liver cancer, nothing seems to be working.

Fri Jun 04, 2010 02:19 AM

Do you have any input on anything that would work on late stage liver cancer.

You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.